<DOC>
	<DOC>NCT00858208</DOC>
	<brief_summary>Efficacy and safety of MACUGEN in patients suffering from neovascular age-related macular degeneration in routine clinical practice at least as good as demonstrated in randomized multicenter clinical trials.</brief_summary>
	<brief_title>Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.</brief_title>
	<detailed_description>Eligible patients in routine clinical practice</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>adults with neovascular agerelated macula degeneration according to SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>efficacy and safety of Macugen in routine clinical practice</keyword>
</DOC>